SPN-810

viloxazine extended-release · Supernus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SPN-810, covering 2021-02-11 to 2025-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems [Phase 2]

See pricing